IndiPharm Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:IndiPharm Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013347
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protocol development, and site monitoring, medical monitoring and QA audits, among others. IndiPharm’s products are used in the therapeutic areas of oncology, infectious diseases, metabolism, diabetes, cardiovascular, neuropsychiatry, pain and rheumatology, women’s health, ophthalmology and medical devices. It offers clinical research services. The organization serves biotechnology, pharmaceutical and medical device companies. The company has its presence in Malaysia and operational center in Mumbai. IndiPharm is headquartered in Wayne, Pennsylvania, the US.

IndiPharm Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IndiPharm Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IndiPharm Inc, Medical Devices Deals, 2011 to YTD 2017 8
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IndiPharm Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
IndiPharm Raises Additional US$1 Million In Venture Financing 10
IndiPharm Raises US$1.2 Million In Venture Financing 11
Private Equity 12
Velocity Fund Partners Acquires IndiPharm 12
IndiPharm Inc – Key Competitors 13
IndiPharm Inc – Key Employees 14
IndiPharm Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
IndiPharm Inc, Pharmaceuticals & Healthcare, Key Facts 2
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
IndiPharm Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
IndiPharm Inc, Medical Devices Deals, 2011 to YTD 2017 8
IndiPharm Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
IndiPharm Raises Additional US$1 Million In Venture Financing 10
IndiPharm Raises US$1.2 Million In Venture Financing 11
Velocity Fund Partners Acquires IndiPharm 12
IndiPharm Inc, Key Competitors 13
IndiPharm Inc, Key Employees 14

★海外企業調査レポート[IndiPharm Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kien Long Commercial Joint Stock Bank (KBC):企業の戦略的SWOT分析
    Kien Long Commercial Joint Stock Bank (KBC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Assembly Biosciences Inc (ASMB):企業の財務・戦略的SWOT分析
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Kvaerner ASA (KVAER):石油・ガス:M&Aディール及び事業提携情報
    Summary Kvaerner ASA (Kvaerner) is a provider of engineering, procurement and construction (EPC) services to steel substructures, topsides, concrete structures and onshore facilities. Its service portfolio includes project management, front-end engineering and design, detailed engineering, construct …
  • Invenergy LLC:企業の戦略的SWOT分析
    Invenergy LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GE Global Research-医療機器分野:企業M&A・提携分析
    Summary GE Global Research (GE Global), a subsidiary of General Electric Company is a research and development company that develops technologies for various industry sectors. The company offers diverse technologies which are used in electronics, chemistry, biosciences, computing, metallurgy, fluid …
  • Genmedica Therapeutics SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Genmedica Therapeutics SL (Genmedica) is a clinical-stage biopharmaceutical company that researches, discovers and develops orally available NCEs for the treatment of diabetes. The company’s expertise spans provides development of specific, dual-action, small molecule inhibitors that targets …
  • Komatsu Ltd (6301):企業の財務・戦略的SWOT分析
    Komatsu Ltd (6301) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Gruppo Banca Sella:企業の戦略・SWOT・財務分析
    Gruppo Banca Sella - Strategy, SWOT and Corporate Finance Report Summary Gruppo Banca Sella - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WestRock Co:戦略・SWOT・企業財務分析
    WestRock Co - Strategy, SWOT and Corporate Finance Report Summary WestRock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Glow Energy Public Co Ltd (GLOW)-エネルギー分野:企業M&A・提携分析
    Summary Glow Energy Public Company Limited (Glow Energy), a subsidiary of Engie S.A., is an energy utility company. It generates and supplies electricity to Electricity Generating Authority of Thailand (EGAT). The company also generates and supplies electricity, steam, processed water and chilled wa …
  • Shriram Transport Finance Company Ltd.:企業のM&A・事業提携・投資動向
    Shriram Transport Finance Company Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shriram Transport Finance Company Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed repo …
  • Belfius Bank Sa
    Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Biocare Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary Biocare Medical LLC (Biocare) develops and supplies automated immunohistochemistry instrumentation and reagents. The company offers androgen receptor, amyloid A, estrogen receptor, ERG, factor xlla and folate receptor alpha IHC assay kit, among others. It offers on-site training, technical s …
  • Globus Medical Inc (GMED):企業の財務・戦略的SWOT分析
    Globus Medical Inc (GMED) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Correvio Pharma Corp (COM):製薬・医療:M&Aディール及び事業提携情報
    Summary Correvio Pharma Corp(Correvio) formerly known as Cardiome Pharma Corp, is a specialty pharmaceutical company, which develops and commercializes therapies for the treatment and prevention of cardiovascular diseases. The company’s product portfolio includes two marketed products: Brinavess, fo …
  • Hyatt Hotels Corporation:企業の戦略・SWOT・財務情報
    Hyatt Hotels Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyatt Hotels Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pyxus International Inc:企業の戦略・SWOT・財務分析
    Pyxus International Inc - Strategy, SWOT and Corporate Finance Report Summary Pyxus International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Adenovir Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Adenovir Pharma AB (Adenovir Pharma) focuses on the development of antiviral pharmaceutical solutions for the treatment of infectious eye diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis (EKC). The company’s APD-209 is topical pharmaceutical product that prevents …
  • Canon Machinery Inc:企業の戦略的SWOT分析
    Canon Machinery Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Village Super Market, Inc.:企業の戦略・SWOT・財務情報
    Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report Summary Village Super Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆